Non-Contrast CT Imaging Market. In 2023, the non-contrast CT imaging market is expected to be worth USD 226.5 million. The ...

Inquis Medical, which is developing therapies for venous thromboembolic diseases, announced the completion of patient ...

Inquis Medical, a leading innovator in venous thromboembolic disease treatment, today announced completion of patient ...

(NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient ...

Argon Medical Devices, a leading provider of device solutions for Interventional Radiology, Vascular Surgery, Interventional ...

Risk for venous thromboembolism during pregnancy increased significantly from 2009 to 2019, with an average annual percent ...

Despite guidelines recommending other anticoagulants for people hospitalized with acute pulmonary embolism (PE), old habits ...

Pulmonary Computed Tomography Angiogram (PCTA) Pulmonary computed tomography angiogram (PCTA) is considered the first-choice diagnostic imaging technique when a pulmonary embolism is suspected. PCTA ...

chronic obstructive pulmonary disease (COPD), and patients who have received a lung transplant. Publishing two complementary papers in Radiology and JHLT Open, the team explain how they use a ...

Up to 50% of patients with pulmonary embolism (PE) experience hemodynamic instability and approximately 70% of patients who die of PE experience an accelerated cascade of symptoms within the first ...